南方通信(01617.HK)中期淨虧1960萬元
格隆匯8月30日丨南方通信(01617.HK)發佈公吿,截至2022年6月30日止六個月,總收入增加約103.1%至約人民幣3.34億元;毛利增加約3.5%至約人民幣1250萬元;毛利率由約7.3%下降至約3.7%;公司擁有人應占期內虧損及綜合開支總額約人民幣1960萬元,同比減少約46.8%;每股虧損人民幣0.013元。
報吿期內,集團的毛利率約3.7%,而上年同期的毛利率約7.3%。其主要原因為銷售年度內新冠疫情反覆,疊加俄烏問題的影響,使得除光纖以外的其他原材料成本(比如有色金屬、部分化工原材料等大宗商品),以及物流運輸成本均有持續上漲,對集團的毛利及毛利率造成不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.